Cargando…

Chylothorax treated with targeted sclerotherapy by direct puncture of the lymphatic leakage site

We report a novel application of targeted sclerotherapy to eradicate high-output chylothorax. The patient underwent thoracic duct embolization; however, cannulation of the thoracic duct failed, and thoracic duct disruption was performed. Leakage continued; therefore, the leakage site in the mediasti...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Masamichi, Inoue, Masanori, Wada, Tomoki, Kawai, Go, Machida, Munetaka, Matsuoka, Yujiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329934/
https://www.ncbi.nlm.nih.gov/pubmed/32636982
http://dx.doi.org/10.1016/j.radcr.2020.06.014
_version_ 1783553004891275264
author Takahashi, Masamichi
Inoue, Masanori
Wada, Tomoki
Kawai, Go
Machida, Munetaka
Matsuoka, Yujiro
author_facet Takahashi, Masamichi
Inoue, Masanori
Wada, Tomoki
Kawai, Go
Machida, Munetaka
Matsuoka, Yujiro
author_sort Takahashi, Masamichi
collection PubMed
description We report a novel application of targeted sclerotherapy to eradicate high-output chylothorax. The patient underwent thoracic duct embolization; however, cannulation of the thoracic duct failed, and thoracic duct disruption was performed. Leakage continued; therefore, the leakage site in the mediastinum was punctured directly under fluoroscopic guidance and a drainage catheter was inserted, followed by sclerotherapy using OK-432. Finally, leakage stopped and chylothorax improved. This technique may be useful for refractory chylothorax in patients where thoracic duct embolization fails.
format Online
Article
Text
id pubmed-7329934
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73299342020-07-06 Chylothorax treated with targeted sclerotherapy by direct puncture of the lymphatic leakage site Takahashi, Masamichi Inoue, Masanori Wada, Tomoki Kawai, Go Machida, Munetaka Matsuoka, Yujiro Radiol Case Rep Interventional Radiology We report a novel application of targeted sclerotherapy to eradicate high-output chylothorax. The patient underwent thoracic duct embolization; however, cannulation of the thoracic duct failed, and thoracic duct disruption was performed. Leakage continued; therefore, the leakage site in the mediastinum was punctured directly under fluoroscopic guidance and a drainage catheter was inserted, followed by sclerotherapy using OK-432. Finally, leakage stopped and chylothorax improved. This technique may be useful for refractory chylothorax in patients where thoracic duct embolization fails. Elsevier 2020-06-29 /pmc/articles/PMC7329934/ /pubmed/32636982 http://dx.doi.org/10.1016/j.radcr.2020.06.014 Text en © 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Interventional Radiology
Takahashi, Masamichi
Inoue, Masanori
Wada, Tomoki
Kawai, Go
Machida, Munetaka
Matsuoka, Yujiro
Chylothorax treated with targeted sclerotherapy by direct puncture of the lymphatic leakage site
title Chylothorax treated with targeted sclerotherapy by direct puncture of the lymphatic leakage site
title_full Chylothorax treated with targeted sclerotherapy by direct puncture of the lymphatic leakage site
title_fullStr Chylothorax treated with targeted sclerotherapy by direct puncture of the lymphatic leakage site
title_full_unstemmed Chylothorax treated with targeted sclerotherapy by direct puncture of the lymphatic leakage site
title_short Chylothorax treated with targeted sclerotherapy by direct puncture of the lymphatic leakage site
title_sort chylothorax treated with targeted sclerotherapy by direct puncture of the lymphatic leakage site
topic Interventional Radiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329934/
https://www.ncbi.nlm.nih.gov/pubmed/32636982
http://dx.doi.org/10.1016/j.radcr.2020.06.014
work_keys_str_mv AT takahashimasamichi chylothoraxtreatedwithtargetedsclerotherapybydirectpunctureofthelymphaticleakagesite
AT inouemasanori chylothoraxtreatedwithtargetedsclerotherapybydirectpunctureofthelymphaticleakagesite
AT wadatomoki chylothoraxtreatedwithtargetedsclerotherapybydirectpunctureofthelymphaticleakagesite
AT kawaigo chylothoraxtreatedwithtargetedsclerotherapybydirectpunctureofthelymphaticleakagesite
AT machidamunetaka chylothoraxtreatedwithtargetedsclerotherapybydirectpunctureofthelymphaticleakagesite
AT matsuokayujiro chylothoraxtreatedwithtargetedsclerotherapybydirectpunctureofthelymphaticleakagesite